- 1.
Luzzatto L, Risitano AM. Advances in understanding the pathogenesis of acquired aplastic anaemia. Br J Haematol 2018; 182: 758–76. [PubMed][CrossRef]
- 2.
Wang L, Liu H. Pathogenesis of aplastic anemia. Hematology 2019; 24: 559–66. [PubMed][CrossRef]
- 3.
Wallerstein RO, Condit PK, Kasper CK et al. Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 1969; 208: 2045–50. [PubMed][CrossRef]
- 4.
Handoko KB, Souverein PC, van Staa TP et al. Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia 2006; 47: 1232–6. [PubMed][CrossRef]
- 5.
Babushok DV, Li Y, Roth JJ et al. Common polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients. Am J Hematol 2013; 88: 862–7. [PubMed][CrossRef]
- 6.
Killick SB, Bown N, Cavenagh J et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 2016; 172: 187–207. [PubMed][CrossRef]
- 7.
Kasahara S, Hara T, Itoh H et al. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor. Br J Haematol 2002; 118: 181–8. [PubMed][CrossRef]
- 8.
Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood 2012; 120: 1185–96. [PubMed][CrossRef]
- 9.
Ogawa S. Clonal hematopoiesis in acquired aplastic anemia. Blood 2016; 128: 337–47. [PubMed][CrossRef]
- 10.
Young NS. Aplastic anaemia. Lancet 1995; 346: 228–32. [PubMed][CrossRef]
- 11.
Bacigalupo A. How I treat acquired aplastic anemia. Blood 2017; 129: 1428–36. [PubMed][CrossRef]
- 12.
Saracco P, Quarello P, Iori AP et al. Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up. Br J Haematol 2008; 140: 197–205. [PubMed][CrossRef]
- 13.
Young NS, Bacigalupo A, Marsh JC. Aplastic anemia: pathophysiology and treatment. Biol Blood Marrow Transplant 2010; 16: S119–25. [PubMed][CrossRef]
- 14.
Marsh J, Schrezenmeier H, Marin P et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 1999; 93: 2191–5. [PubMed][CrossRef]
- 15.
Scheinberg P. Activity of eltrombopag in severe aplastic anemia. Blood Adv 2018; 2: 3054–62. [PubMed][CrossRef]
- 16.
Townsley DM, Dumitriu B, Liu D et al. Danazol treatment for telomere diseases. N Engl J Med 2016; 374: 1922–31. [PubMed][CrossRef]
- 17.
Townsley DM, Scheinberg P, Winkler T et al. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med 2017; 376: 1540–50. [PubMed][CrossRef]
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.